AJTMH ASTMH Job Mart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am. J. Trop. Med. Hyg., 62(6), 2000, pp. 698-701
Copyright © 2000 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sardelis, M.
Right arrow Articles by Turell, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sardelis, M.
Right arrow Articles by Turell, M.
Related Collections
Right arrow Viral Hemorrhagic Fevers
Right arrow Dengue
Right arrow Mosquitoes
American Journal of Tropical Medicine and Hygiene, Vol 62, Issue 6, 698-701
Copyright © 2000 by American Society of Tropical Medicine and Hygiene

Research Articles


Limited potential for transmission of live dengue virus vaccine candidates by Aedes aegypti and Aedes albopictus

MR Sardelis, R Edelman, TA Klein, BL Innis, Putnak JR, JW Jones, and MJ Turell

To evaluate the transmission risk of four live dengue (DEN) vaccine candidates developed by the U.S. Army (DEN-1, 45AZ5 PDK 20; DEN-2, S16803 PDK 50; DEN-3, CH53489 PDK 20; and DEN-4, 341750 PDK 20), we tested 3,010 Aedes aegypti and 1,576 Aedes albopictus mosquitoes blood-fed on 21 volunteers who had been administered one of the four vaccine candidates or the licensed yellow fever (YF) vaccine (17D). We used an indirect immunofluorescence assay (IFA) to detect DEN or YF viral antigen in the heads of mosquitoes. Corresponding to the lack of a detectable viremia among volunteers inoculated 8-13 days previously with live DEN-1 or DEN-2 vaccine candidates, only six mosquitoes developed disseminated infections after feeding on these volunteers. These six mosquitoes included 4 of 247 Ae. albopictus fed on volunteers inoculated with the DEN-1 vaccine candidate and 2 of 528 Ae. aegypti fed on volunteers inoculated with the DEN-2 vaccine candidate. Infection was confirmed in each of these IFA-positive mosquitoes by isolating infectious virus from the mosquito's body in Vero-cell culture. None of the 1,252 or the 969 mosquitoes fed on DEN-3 or DEN-4 recipients, respectively, were infected. Overall, dissemination rates in Ae. albopictus and Ae. aegypti were low. Dissemination rates were 0.5%, 0.3%, < 0.1%, and < 0.1% for the DEN-1 through DEN-4 vaccine candidates, respectively. Because of the observed low dissemination rates, it is unlikely that these vaccine viruses would be transmitted under natural conditions.


This article has been cited by other articles:


Home page
 Am J Trop Med HygHome page
W. SUN, R. EDELMAN, N. KANESA-THASAN, K. H. ECKELS, J. R. PUTNAK, A. D. KING, H.-S. HOUNG, D. TANG, J. M. SCHERER, C. H. HOKE JR., et al.
VACCINATION OF HUMAN VOLUNTEERS WITH MONOVALENT AND TETRAVALENT LIVE-ATTENUATED DENGUE VACCINE CANDIDATES
Am J Trop Med Hyg, December 1, 2003; 69(2007): 24 - 31.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
R. Cologna and R. Rico-Hesse
American Genotype Structures Decrease Dengue Virus Output from Human Monocytes and Dendritic Cells
J. Virol., April 1, 2003; 77(7): 3929 - 3938.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
S. Craig, H. M. Thu, K. Lowry, X.-f. Wang, E. C. Holmes, and J. Aaskov
Diverse Dengue Type 2 Virus Populations Contain Recombinant and Both Parental Viruses in a Single Mosquito Host
J. Virol., April 1, 2003; 77(7): 4463 - 4467.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the American Society of Tropical Medicine and Hygiene.